Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Next Generation Sequencing: Research to Clinic
Conferences  \  Past Conferences  \  Next Generation Sequencing: Research to Clinic
RegisterLogin

Next Generation Sequencing: Research to Clinic


Keynote Speakers


Nazneen Aziz
Director, College of American Pathologists


Paul Billings
Chief Medical Officer, Life Technologies


Charles Cantor
Chief Scientific Officer, Sequenom Inc


Michael Heller
Professor, Dept Bioengineering, University of California-San Diego


Doron Lipson
Director, Foundation Medicine

Overview

SELECTBIO is hosting its Next Generation Sequencing: Research to Clinic Conference to bring together delegates from around the world focusing on technology development, informatics/data analysis, and applications of next generation sequencing (NGS) in various research fields and the migration of NGS towards the clinic.

In this conference, there are presentations and panel discussions focusing on sample-preparation for NGS, NGS instrumentation, NGS data analysis/big data, and most-importantly the universe of applications being developed for the use of NGS in the discovery and interrogation of biomarkers, especially in oncology.  As NGS permeates the cancer biomarker realm and cost of NGS declines, there is the opportunity and hope to deploy NGS as a means to personalize cancer diagnostics and therapeutics.

Agenda Topics

  • Front-end Sample Preparation for NGS
  • Informatics and Data Handling/Analysis
    • NGS Big Data Handling
  • New Technology Development in NGS
    • Instrumentation Platforms
    • Reagent Offerings
  • NGS for Clinical Testing
    • NGS in Non-Invasive Prenatal Testing (NIPT)
    • Oncology Space and the Penetrance of NGS in Cancer Mutation Discovery
    • Regulatory Landscape and Commercial Trends
  • NGS for Development of Therapeutic Antibodies and Vaccines
  • NGS on Rare Cells (such as Circulating Tumor Cells)
  • Research Trends and Applications of NGS
    • Discovery of Mutations and Potential Biomarkers
    • Epigenetic Modifications
    • NGS on Exosomes, Extracellular Vesicles, and Biological Fluids
    • RNA-Seq

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Jiang Zhu, Assistant Professor, The Scripps Research Institute
Nicole zur Nieden, Assistant Professor, University of California Riverside
Akira Watanabe, Assistant Professor, Kyoto University
Frank Ong, Associate Director, Illumina Inc
Denis Smirnov, Associate Scientific Director, Janssen Pharmaceuticals
Martin Siaw, Associate Scientific Director, Quest Diagnostics Nichols Institute
Gitte Pedersen, Chief Executive Officer, Genomic Expression
Shawn Baker, Chief Science Officer/Chief Executive Officer, AllSeq Inc
Jennifer Friedman, Clinical Professor of Neurosciences and Pediatrics, Rady Children's Hospital in San Diego
Raimo Tanzi, Director, Silicon Biosystems SPA
Jonathan Hirsch, Founder and President, Syapse
Theral Timpson, Host and Producer, Mendelspod
Timo Faltus, Investigator, TRM Leipzig
Heidrun Holland, Investigator, TRM Leipzig
Swaroop Aradhya, Medical Geneticist, InVitae Corporation
Yongjun Chu, Postdoctoral Fellow, University of Texas Southwestern Medical Center
Jorge Leon, President, Leomics Associates Inc
Suraj Bhat, Professor, University Of California Los Angeles
Andrew Hill, Professor and ARC Future Fellow, The University of Melbourne
Melanie Lehman, Research Scientist, Queensland University of Technology
Mark Adams, Scientific Director, J Craig Venter Institute

Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks